FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma

Figure 2

The prognostic value of FCGBP in OSCC patients. (a, b) Kaplan-Meier curves of the overall survival and progression-free survival of OSCC patients. (c, d) Univariate and multivariate assays of overall survival in OSCC cases.

(a)

(b)

(c)

(d)